Fentanyl Dealers May Face Murder Charges In San Francisco By Zachary Pottle ❘ November 3, 2023 A new task force aimed at battling the Opioid crisis in San Francisco may allow law enforcement to treat deadly overdoses as homicides. Read More
Purdue Pharma’s $6 Billion Opioid Settlement Blocked By Supreme Court By Jessica Sherer ❘ August 11, 2023 On Thursday, the Supreme Court blocked bankruptcy proceedings for Purdue Pharma, the makers of OxyContin, an extremely addictive Opioid. Read More
3-Year Investigation Of Drug Cartel Yields Millions Worth Of Drugs By Carmen McCrackin ❘ March 13, 2023 The DEA and the Tempe police nabbed 4.5 million Fentanyl pills and more after a 3-year investigation of prominent drug cartels. Read More
Four States To Receive Millions In Opioid Settlements By Carmen McCrackin ❘ April 28, 2022 Over the past 2 weeks, Alabama, Central New York, West Virginia, and California have received Opioid settlements tallying up to $390 million. Read More
Florida Vs Pharmacies: Fueling The Opioid Crisis? By Hannah Zwemer ❘ April 12, 2022 Roughly 39,000 Florida residents have died due to Opioids over the past 20 years. Walgreens is next on the list of the state's prosecutions. Read More
WNBA Star Arrested In Russia On Drug Charges By Carmen McCrackin ❘ March 10, 2022 As the war between Ukraine and Russia continues, WNBA's Brittney Griner's detainment in Russia adds a layer of tension in the US. Read More
J&J $26 Billion Opioid Settlement Finalized By Carmen McCrackin ❘ March 2, 2022 Johnson & Johnson and 3 major drug distributors will foot the bill of a $26 billion settlement to help rebuild Opioid-stricken communities. Read More
Pregnant Women Facing Incarceration For Drug Abuse By Hannah Zwemer ❘ January 17, 2022 Women in Oklahoma are facing incarceration for drug abuse during their pregnancy. One woman's case sparked outrage. Read More
Holdout State Joins Johnson & Johnson Settlement By William Henken ❘ January 5, 2022 Nevada has backed a multibillion-dollar Opioid settlement. The implications are big. Drug companies are in hot water; payouts may arrive soon. Read More
